- ACADIA Pharma (NASDAQ:ACAD) is scheduled to announce Q1 earnings results on Wednesday, May 5th, after market close.
- The consensus EPS Estimate is -$0.53 (+7.0% Y/Y) and the consensus Revenue Estimate is $112.01M (+24.4% Y/Y).
- Over the last 2 years, ACAD has beaten EPS estimates 63% of the time and has beaten revenue estimates 75% of the time.
- R&D expense estimate of $71.2M.
- SG&A expense estimate of $123.1M.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 4 downward. Revenue estimates have seen 0 upward revisions and 6 downward.
ACADIA Pharma Q1 2021 Earnings Preview
Recommended For You
More Trending News
About ACAD Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ACAD | - | - |
| ACADIA Pharmaceuticals Inc. | ||